The award jury
recognizes strategic and sustainable corporate management ●
Vetter’s strategic focus and long-term approach
earn repeated recognition ●
Honored for economic success and sustainability ●
Award focuses on family-owned companies in 2025 Ravensburg, May 27, 2025: Vetter, a globally operating Contract Development and Manufacturing
Organization (CDMO), has been named Best Managed Company in its
anniversary year for the sixth time in a row. For 75 years, the family-owned
company has stood for quality, responsibility,
and a strong commitment to improving the quality of life of patients worldwide. The award demonstrates how Vetter pursues its
strategic goals in a focused and action-driven manner. The jury recognizes the
company’s long-term thinking as a key success factor. The Best Managed
Companies Award is organized by Deloitte Private, UBS, the Frankfurter
Allgemeine Zeitung, and the Bundesverband der Deutschen Industrie e.V.
(Federation of German Industries). The trophy and certificate were presented to
the CDMO at an awards ceremony on May 22 at the Gesellschaftshaus Palmengarten
in Frankfurt, Germany. Markus Seiz, Best Managed Companies
Program Lead and Director at Deloitte Private says: “Vetter is an example of how
critical it is for actions to align with core values in order to achieve
economic success as a globally active family business. In our opinion, the trusted
pharmaceutical service provider is one of the pioneers of sustainable and
innovative corporate management in the way it combines its strategic vision and
responsible business practices.” To earn the Best Managed Companies
Award, a company must convince the high-caliber jury across four key business
areas known as “value drivers,” including: strategy; productivity and
innovation; culture and commitment; and governance and finance. After a
personal coaching session, the participating companies answer an extensive and
detailed questionnaire. In 2025, for the first time, the jury also evaluated
criteria that are geared towards the specific values and unique profiles of
family businesses. Vetter impressed in all four areas due to its consistency in
driving forward and developing its projects and processes in line with its
corporate values. Vetter Managing
Director Titus Ottinger emphasizes: “Participating in the Best Managed
Companies Award enables us to receive valuable feedback through a stringent
external selection process. This feedback is very important for us, as it comes
from experienced professionals in a wide range of fields, whose perspectives
allow us to further grow. This year, we were able to show even more explicitly
how deeply we have anchored the values of our family business in our day-to-day
operations. This new facet of the program makes the award even more valuable to
us.” With 11% sales growth reaching 1.1
billion euros in 2024, Vetter demonstrates how its consistent focus on all four
value drivers results in meaningful business outcomes. The results for 2024 are
also positive in other areas. For example, the CDMO continued its growth in
employment, now with 7,000 global employees. With investments of 269 million
euros in the expansion and modernization of its sites in Germany, Austria, and
the U.S., Vetter continues to invest in its dynamic and organic growth in the
production of complex injectable drugs. In a politically and economically
challenging environment, the CDMO is proving to be a secure employer and
reliable partner for pharma and biotech companies worldwide. The strategic focus of the
company’s development in 2024 was once again on the reliability and
high-quality of the services offered, sustainable growth, and advancing digital
transformation in all facets of the company. Numerous projects for the
digitization of production processes and in the areas of AI, human-machine
interaction, cloud and cyber security are currently underway or have already
been completed. With a comprehensive innovation management process
characterized by interactive formats, Vetter’s employees prioritize identifying
trends and technologies early on. For many years, the CDMO has placed a
strategic focus on sustainability in the areas of ecology, economy, and social
issues. The family-owned company published its fourth comprehensive
sustainability report earlier this year. About Vetter Vetter
is a leading Contract Development and Manufacturing Organization (CDMO) with
headquarters in Ravensburg, Germany, and production facilities in Germany,
Austria, and the US. As a global player, the independent pharmaceutical service
provider is also present in the Asia-Pacific markets of Japan, China, South
Korea and Singapore with sales locations. Around the world, small and large
renowned pharma and biotech companies rely on the decades of experience, high
quality, modern technologies, reliability, and commitment of its more than 7,000 employees. In close partnership
with its customers, the Vetter team supplies patients all over the world with
medicines, many of which are vital. The CDMO provides support from drug product
development through clinical and commercial filling to a wide range of assembly
and packaging services for vials, syringes, and cartridges. With innovative
solutions, Vetter develops prefilled drug-delivery systems together with its
customers to continuously improve patient safety, comfort, and compliance. The
company is an industry pioneer in sustainability and a socially and ethically
responsible corporate citizen. The CDMO is a member of the UN Global Compact
and Science Based Target initiative (SBTi) and received gold status in
the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership
Awards, Frost
& Sullivan Customer Value Leadership Award and the recognition
as Best Managed Company emphasize Vetter’s commitment to sustainable
business. Founded in Ravensburg in 1950, the company remains family-owned to
this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn. Contact Vetter Pharma International
GmbH Markus Kirchner Corporate Spokesperson / Media
Relations Eywiesenstrasse 5 88212 Ravensburg, Germany Phone: +49 (0)751-3700-3729 E-mail: PRnews@vetter-pharma.com
© Vetter Pharma International GmbH: Senator h.c. Udo J. Vetter, Chairman of the
Advisory Board and member of the owner family (second from right) along with
Vetter Managing Director Titus Ottinger (second from left), Holger Loesch,
Deputy Director General of the Federation of German Industries (first from
left) and moderator Susanne Schoene, at the presentation of the Best Managed
Companies Award.
